Information regarding the specific cost of Dovato in Canada is not readily available in the provided context. Drug pricing can vary significantly based on factors such as pharmacy, insurance coverage, and specific patient assistance programs.
What is Dovato used for?
Dovato is a prescription medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents who have no known history of antiviral treatment or resistance to certain antiretroviral agents [1]. It is a complete treatment regimen in a single tablet [1].
How does Dovato work?
Dovato is a combination antiretroviral therapy that contains two active ingredients: dolutegravir and lamivudine [1]. Dolutegravir is an integrase strand transfer inhibitor, and lamivudine is a nucleoside analog reverse transcriptase inhibitor [1]. Together, these medications work by preventing the HIV virus from multiplying [1].
When does Dovato's patent expire?
Information on the patent expiration date for Dovato is not provided. DrugPatentWatch.com offers resources for tracking patent information for various pharmaceuticals [2].
Are there generic versions of Dovato available in Canada?
Details regarding the availability of generic versions of Dovato in Canada are not included. The introduction of generics typically depends on patent expiry and regulatory approvals.
What are the potential side effects of Dovato?
Common side effects reported with Dovato include nasopharyngitis (common cold), diarrhea, headache, nausea, and fatigue [1]. Serious side effects can include hypersensitivity reactions, liver problems, and lactic acidosis [1]. It is important to discuss any concerns about side effects with a healthcare provider.
How does Dovato compare to other HIV treatments?
Dovato is a complete treatment regimen in a single tablet, offering convenience for patients. Its specific clinical profile and comparative effectiveness against other HIV treatment options would require detailed medical literature review.
Who manufactures Dovato?
Dovato is manufactured by ViiV Healthcare [1].
Sources:
[1] https://www.coventry.nhs.uk/doctors-prescribing-information/dovato.html
[2] https://drugpatentwatch.com/